At a glance
ClinicalIndex Comparison RecordN/ACompleted· 200 enrolled
Drug / intervention
tiotropium +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Tiotropium Respimat Soft Mist Inhaler Versus HandiHaler to Improve Sleeping Oxygen Saturation and Sleep Quality in COPD.
In Brief
A clinical study evaluating tiotropium, Handihaler, and 1 other intervention for Chronic Obstructive Pulmonary Disease. Completed, enrolled 200 participants.
Detailed Summary
The aim of this study was to compare the tiotropium Respimat Soft Mist Inhaler and the HandiHaler in terms of their effects on sleeping oxygen saturation (SaO2) and sleep quality in patients with COPD.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Obstructive Pulmonary Disease
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2010
Primary CompletionDec 2013
Study CompletionSep 2014
First PostedJan 2015
TodayJul 2026
First PostedJan 6, 2015
Enrollment StartMar 1, 2010
Primary CompletionDec 1, 2013
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 11.5 years ago
Interventions
tiotropiumdrug
Comparison of the effect of tiotropium delivered by the Respimat Soft Mist Inhaler versus the HandiHaler on sleeping oxygen saturation and sleep quality in patients with COPD.
Handihalerdevice
Inhalation via the HandiHaler once daily
Respimatdevice
Inhalation via the Respimat once daily